The Patent Finder

Terms ending in 2036

Genmab A/S

Every in-force patent on Genmab A/S's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,457,735Methods of Inducing T Cell Activation by Administering an Antibody Comprising CD40 and 4-1BB (CD137) Binding Domains
In force
 · High confidence
BioNTech SEIn forceHigh confidence
US 10,927,181Agonistic Tumor Necrosis Factor (TNF) Receptor Binding Agents
In force
 · High confidence
BioNTech SEIn forceHigh confidence
US 12,421,319Binding Agents That Bind OX40 (CD134) and Method of Use Thereof to Treat Disease
In force
 · High confidence
BioNTech SEIn forceHigh confidence
US 12,799,229Bispecific and Multispecific Antibodies and Method for Isolation of Such
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 11,814,411Nucleic Acid Molecules Encoding Binding Agents to CD40 and 4-1BB (CD137)
In force
 · High confidence
BioNTech SEIn forceHigh confidence
US 10,364,285Agents, Uses and Methods for the Treatment of Synucleinopathy
In force
 · High confidence
H. Lundbeck A/SIn forceHigh confidence
US 10,428,147Anti-Sortilin Antibodies, Uses and Methods for Treatment
In force
 · High confidence
H. Lundbeck A/SIn forceHigh confidence
US 10,479,835Agent, Uses and Methods for Treatment
In force
 · High confidence
H. Lundbeck A/SIn forceHigh confidence
US 10,640,554Agents, Uses and Methods for the Treatment of Synucleinopathy
In force
 · High confidence
H. Lundbeck A/SIn forceHigh confidence
US 10,647,763Agents, Uses and Methods for the Treatment of Synucleinopathy
In force
 · High confidence
H. Lundbeck A/SIn forceHigh confidence
12 more term ends in 2036 · Pro
10 of 22 patents shown. Soonest term end first, then patent number.
Pro members see all 22.
Upgrade to Pro
4 of these are in force and held by Genmab A/S.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited